PLATIN SALTS-INDUCED HEMOLYTIC-ANEMIA - CISPLATIN-INDUCED AND THE FIRST CASE OF CARBOPLATIN-INDUCED HEMOLYSIS

Citation
F. Maloisel et al., PLATIN SALTS-INDUCED HEMOLYTIC-ANEMIA - CISPLATIN-INDUCED AND THE FIRST CASE OF CARBOPLATIN-INDUCED HEMOLYSIS, Anti-cancer drugs, 6(2), 1995, pp. 324-326
Citations number
15
Categorie Soggetti
Oncology,"Pharmacology & Pharmacy
Journal title
ISSN journal
09594973
Volume
6
Issue
2
Year of publication
1995
Pages
324 - 326
Database
ISI
SICI code
0959-4973(1995)6:2<324:PSH-CA>2.0.ZU;2-G
Abstract
Anemia is a common side effect of cisplatin, especially after repeated infusions. The primary mechanism is a myelosuppression caused by cisp latin's interference with iron metabolism, resulting in a lower count of red cell precursors. Some authors report a hemolytic anemia similar to penicillin-induced anemia, in which hemolysis is caused by an anti globulin antibody directed against red cell membrane-bound cisplatin. The authors report two cases of cisplatin-induced anemia and suggest t hat the immune-complex hypothesis is responsible for hemolysis. The fi rst case of carboplatin-induced hemolysis is also reported. Mechanisms of hemolysis and clinical practice are discussed.